Viewing StudyNCT03930771



Ignite Creation Date: 2024-05-06 @ 1:06 PM
Last Modification Date: 2024-10-26 @ 1:08 PM
Study NCT ID: NCT03930771
Status: TERMINATED
Last Update Posted: 2022-08-09
First Post: 2019-04-25

Brief Title: Capecitabine and Temozolomide for Treatment of Recurrent Pituitary Adenomas
Sponsor: Weill Medical College of Cornell University
Organization: Weill Medical College of Cornell University

Conditions & Keywords Data

Conditions:
Name
Recurrent Pituitary Adenomas
Keywords: